Everything you need to know about the latest Cochlear dividend

Investors have reacted savagely to Cochlear today.

Sebastian Bowen

Author Bio Sebastian Bowen has been a Motley Fool contributor since late 2018. Sebastian found his passion for writing and educating others about shares and all things finance after completing his studies in political, economic and social science and enjoys bringing this passion to life at the Fool. His investment philosophy is a simple one – buying high-quality companies at prices that make sense. When he’s not researching his next investment at all hours of the morning, Sebastian enjoys classic movies and likes to unwind with a good book, newspaper or record. Areas of Expertise Dividend investing ETFs Education Bachelor of Political, Economic, and Social Sciences (Government and International Relations), University of Sydney Social Media X/Twitter Favorite Investment Quote "In the short run, the market is a voting machine, but in the long run, it is a weighing machine." – Benjamin Graham

Published February 13, 2:10 pm AEDT

ASX earnings season continues this Friday, with the latest numbers coming in from a few ASX 200 shares today. One of the ASX 200 shares reporting today is healthcare stock Cochlear Ltd (ASX: COH). And boy, are Cochlear's latest numbers and new dividend, prompting a dramatic reaction from the markets.

The company, best known for its hearing implants, revealed its financial results for the six months to 31 December 2025 this morning. And they caused quite the stir.

As we covered earlier this session, Cochlear reported half-year sales revenue of $1.18 billion, up just 1% on the prior corresponding period.

It didn't get any better from there. Cochlear also revealed a statutory net profit of $161.5 million, down a nasty 21%. Underlying profits were a little better, but still came in at $195 million, a drop of 9% from the same period in 2024.

Investors are reacting savagely to what Cochlear had to say today. The healthcare stock closed at $245.64 a share yesterday afternoon. However, investors have sent those shares down a horrid 17.7% at the time of writing to just $202.24.

But let's discuss Cochlear's latest dividend.

A woman leans forward with her hand behind her ear, as if trying to hear information. — Image source: Getty Images

Cochlear shares crash 17% on lower profits, but dividend steady

Over the past few years, Cochlear has built up a reputation as a decent ASX dividend growth stock. The company paid out $2.55 per share in annual dividends back in 2021, and has been increasing them ever since. Shareholders enjoyed a total payout of $3 per share in 2022, $3.30 in 2023, $4.10 in 2024 and $4.30 in 2025. That's a compounded annual growth rate of 13.95% per annum.

Unfortunately, that dividend growth reputation is now at risk. Today, Cochlear unveiled a 2026 interim dividend of $2.15 per share. That's flat on both last year's interim payment and last year's final dividend, both also worth $2.15 a share. This latest dividend represents a payout ratio of 72% of Cochlear's underlying earnings, slightly above the company's 70% payout ratio policy.

This dividend will come partially franked at 85%.

Cochlear shares will trade ex-dividend for this payment on 19 March next month. Payment day will then roll around on 13 April. The company does not have a dividend reinvestment plan (DRP) in operation, so shareholders will have no option but to receive this payment in cash.

As Cochlear's interim dividend is steady, the company now trades on both a trailing and forward dividend yield of 2.13% at current pricing.

Automatic Renewal

By taking up this offer, you will also be enrolled in our auto-renewal program, which is our way of making your ongoing subscription easier by ensuring uninterrupted service. Don't worry, though – you're not locked in, and can cancel your auto-renewal at any time before each 'anniversary' date without question or penalty.